Ratings agency cited uncertainty over planned capital injections and ongoing regulatory changes as key factors in its latest review of the Indonesian insurer.
Building on record VNB growth in 2025, the insurer sustained its momentum into the first quarter of 2026, supported by strong growth in new business volumes.